Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
Types of Radioactivity03:23

Types of Radioactivity

The most common types of radioactivity are α decay, β decay, γ decay, neutron emission, and electron capture.
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic health conditions and trajectories of depressive symptoms in late adulthood: role of age-friendly community.

Journal of epidemiology and community health·2026
Same author

Depressive symptoms in people with late effects of polio and the association with sociodemographic and disability-related factors.

PM & R : the journal of injury, function, and rehabilitation·2025
Same author

A feasibility study of the internet-based intervention "Strategies for Empowering activities in Everyday life" (SEE 1.0) applied for people with stroke.

BMC health services research·2025
Same author

Self-reported sleep disturbances and its determinants in people 1 year or more after stroke: A cross-sectional study.

PM & R : the journal of injury, function, and rehabilitation·2025
Same author

Self-reported physical activity more than 1 year after stroke and its determinants in relation to the WHO recommendations.

PM & R : the journal of injury, function, and rehabilitation·2025
Same author

Can the internet based intervention 'strategies for empowering activities in everyday life' support people with cognitive difficulties to self-manage digital work and everyday life?

Scandinavian journal of occupational therapy·2024

Related Experiment Video

Updated: May 26, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Patient-specific alpha-particle dosimetry.

Stig Palm1, Jörgen Elgqvist, Lars Jacobsson

  • 1Dosimetry and Medical Radiation Physics Section, International Atomic Energy Agency (IAEA), Vienna, Austria.

Current Radiopharmaceuticals
|December 29, 2011
PubMed
Summary
This summary is machine-generated.

Alpha-particle therapy shows promise due to new targeting and labeling methods. Accurate dosimetry is crucial for optimizing this targeted cancer treatment and improving patient outcomes.

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Related Experiment Videos

Last Updated: May 26, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Area of Science:

  • Nuclear medicine
  • Radiotherapy
  • Medical physics

Background:

  • Alpha-particle therapy is gaining traction due to advancements in targeting constructs, labeling techniques, and radionuclide availability.
  • This therapy utilizes alpha (α)-particle emitting radionuclides for targeted cancer treatment.

Purpose of the Study:

  • To review methods for estimating absorbed dose in tumors and healthy tissues during alpha-particle therapy clinical trials.
  • To compare alpha-particle dosimetry with conventional beta (β)-particle emitter therapies.
  • To discuss challenges and potential benefits of patient-specific dosimetry in alpha-particle therapy.

Main Methods:

  • Overview of dosimetry methods employed in clinical trials for alpha-particle therapy.
  • Comparative analysis of dosimetry approaches for alpha-particle versus beta-particle emitters.
  • Discussion of challenges in establishing accurate patient-specific dosimetry for alpha particles.

Main Results:

  • Various methods exist for estimating absorbed dose in clinical settings for alpha-particle therapy.
  • Significant differences and similarities exist between alpha- and beta-particle dosimetry.
  • Accurate, patient-specific dosimetry presents unique challenges but may enhance therapeutic efficacy.

Conclusions:

  • Dosimetry is a critical component of alpha-particle therapy clinical implementation.
  • Addressing dosimetry challenges can lead to more effective and personalized cancer treatments.
  • Further research into patient-specific dosimetry is warranted to maximize the benefits of alpha-particle therapy.